Showing 1,523 results

Filters Content type: News, Editors' picks, About HIV Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

New & experimental hepatitis C treatment

Gilead, Abbott Unwrap Dueling Hep C Pill Data

Editor's pick
The Street
12 November 2012
Access to healthcare

Study shows drug patents can be extended for decades

Editor's pick
Intellectual Property Watch
12 November 2012
New & experimental hepatitis C treatment

Boehringer Ingelheim to start late-stage hepatitis C drug trial

Editor's pick
Reuters
11 November 2012
New & experimental hepatitis C treatment

Idenix Reports On IDX719 and IDX184

Editor's pick
Idenix press release
11 November 2012
Pharmaceutical industry

Drugmakers offer to cap Greece's medicines bill

Editor's pick
Reuters
8 November 2012
Pharmaceutical industry

Gilead's Stribild to reinforce HIV/AIDS revenues as key patents expire

Editor's pick
The Pharma Letter
8 November 2012
New & experimental hepatitis C treatment

Merck will initiate interferon-free Phase II clinical trials for MK-5172, an investigational, once-daily, oral treatment for chronic hepatitis C virus

Editor's pick
Merck press release
6 November 2012
New & experimental hepatitis C treatment

Copy of Merck will initiate interferon-free Phase II clinical trials for MK-5172, an investigational, once-daily, oral treatment for chronic hepatitis C virus

Editor's pick
Merck press release
6 November 2012
Pharmaceutical industry

Drugmakers offer to cap Greece's medicines bill

Editor's pick
Reuters
6 November 2012
Pharmaceutical industry

Gilead and the Pharmasset Deal: Do the Ends Justify the Means?

Editor's pick
PropThink
5 November 2012
Access to healthcare

Hope for hep-c patients: Patients succeed in overturning first ever product patent on medicine in India

Editor's pick
Lawyers' Collective
2 November 2012
New & experimental hepatitis C treatment

Vertex Joins Glaxo, J&J in Testing Hepatitis C Combos

Editor's pick
Bloomberg BusinessWeek
1 November 2012
New & experimental HIV treatments

Gilead: HIV drug meets key Phase 2 trial objective

Editor's pick
Gilead press release
31 October 2012
New & experimental hepatitis C treatment

Achillion Pharma Worthy of New Look - TheStreet.com

Editor's pick
Google Alerts - Hepatitis
31 October 2012
Hepatitis C symptoms & diagnosis

bioMérieux launches antibody test for hepatitis C

Editor's pick
MTBeurope
31 October 2012
HIV treatment for children & young people

Prezista® (darunavir) oral suspension receives European Commission approval for young children with HIV-1 infection

Editor's pick
Janssen-Cilag press release
30 October 2012
Pharmaceutical industry

Glaxo & Pfizer rejig joint venture deal with Shionogi

Editor's pick
ShareCast
29 October 2012
Pharmaceutical industry

Buy Gilead Sciences: HIV And Hepatitis Drugs To Drive Growth

Editor's pick
Seeking Alpha
25 October 2012
Pharmaceutical industry

Gilead Sciences Revenue Jumps 14%, Helped by HIV Drugs

Editor's pick
NASDAQ
24 October 2012
Pharmaceutical industry

Questions and answers on the assessment of the deficiencies in the safety reporting system at Roche Registration Ltd

Editor's pick
European Medicines Agency
23 October 2012
Generic medicines

The generic generation

News
22 October 2012
Pharmaceutical industry

Humira drives Abbott growth again, 550 jobs cut

Editor's pick
Pharma Times
19 October 2012
Pharmaceutical industry

India's Cipla gets tentative U.S. nod for HIV tablets

Editor's pick
Reuters
19 October 2012
Pharmaceutical industry

Vertex Draws Collaboration Interest For Hepatitis C Combo

Editor's pick
Bloomberg BusinessWeek
19 October 2012